Lndip 20 Tablet contains Cilnidipine 20 mg, a calcium channel blocker used primarily for the management of hypertension. Cilnidipine exerts its antihypertensive effect by inhibiting the influx of calcium ions through L-type and N-type calcium channels in vascular smooth muscle and sympathetic nerve endings, leading to vasodilation and reduced peripheral vascular resistance. This dual action not only lowers blood pressure effectively but also helps in reducing sympathetic nerve activity, which may contribute to improved cardiovascular outcomes. Lndip 20 is indicated for the treatment of essential hypertension and may be used as monotherapy or in combination with other antihypertensive agents to achieve optimal blood pressure control. The medication is generally well tolerated, with common adverse effects including dizziness, headache, flushing, and peripheral edema. It is contraindicated in patients with known hypersensitivity to Cilnidipine or other dihydropyridine calcium channel blockers. Caution is advised in patients with severe hepatic impairment or heart failure. Regular monitoring of blood pressure and clinical status is recommended during therapy. Lndip 20 Tablet should be used under medical supervision, adhering to prescribed dosages to minimize risks and ensure therapeutic efficacy.